Mark A. Watson
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
- Oncology 30
- Cancer Cells and Metastasis 16
- Colorectal Cancer Treatments and Studies 5
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Jeffrey Milbrandt (10 shared papers)Timothy P. Fleming (11 shared papers)David H. Gutmann (14 shared papers)Arie Perry (12 shared papers)Rakesh Nagarajan (9 shared papers)Toshiyuki Araki (2 shared papers)Veronica I. Luzzi (3 shared papers)John P. Svaren (2 shared papers)
- Journals
- Clinical Cancer Research (7 papers)Cancer Research (5 papers)Breast Cancer Research and Treatment (5 papers)Oncogene (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Mark A. Watson
109 papers receiving 7.4k citations
Peers
Comparison fields: 5 of 154
- Cancer Research 1.5k
- Oncology 1.6k
- Molecular Biology 3.2k
- Neurology 651
- Genetics 420
Countries citing papers authored by Mark A. Watson
This map shows the geographic impact of Mark A. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Watson more than expected).
Fields of papers citing papers by Mark A. Watson
This network shows the impact of papers produced by Mark A. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Watson. The network helps show where Mark A. Watson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 442 | |
| 2 | 2011 | 409 | |
| 3 | Expression profiling reveals hepsin overexpression in prostate cancer. | 2001 | 330 |
| 4 | 2012 | 295 | |
| 5 | Association of prostate cancer with vitamin D receptor gene polymorphism. | 1996 | 278 |
| 6 | Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. | 1996 | 272 |
| 7 | 2006 | 262 | |
| 8 | 2001 | 227 | |
| 9 | 2009 | 183 | |
| 10 | 2005 | 172 | |
| 11 | 2006 | 168 | |
| 12 | 2000 | 156 | |
| 13 | 1989 | 155 | |
| 14 | Mammaglobin expression in primary, metastatic, and occult breast cancer. | 1999 | 147 |
| 15 | 2013 | 145 | |
| 16 | 2007 | 134 | |
| 17 | 2003 | 115 | |
| 18 | 2009 | 113 | |
| 19 | 2009 | 112 | |
| 20 | 2001 | 108 |
About Mark A. Watson
Mark A. Watson is a scholar working on Oncology, Cancer Research, Molecular Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 112 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Molecular Biology Techniques and Applications (12 papers), Cancer Genomics and Diagnostics (8 papers), Gene expression and cancer classification (8 papers), Neurofibromatosis and Schwannoma Cases (8 papers), Glioma Diagnosis and Treatment (7 papers), Genetic factors in colorectal cancer (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.6k citations), Molecular Biology (3.2k citations), Neurology (651 citations) and Genetics (420 citations). Mark A. Watson has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jeffrey Milbrandt, Timothy P. Fleming, David H. Gutmann, Arie Perry, Rakesh Nagarajan, Toshiyuki Araki, Veronica I. Luzzi, John P. Svaren, Torsten Ehrig and Peter A. Humphrey. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Breast Cancer Research and Treatment, Oncogene and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.